PTPA and colorectal carcinoma: Several published works have reported that functional inactivation of PP2A is common and has great importance in CRC [8,9,10,11], and that overexpression of the endogenous PP2A inhibitor SET [12] is a key molecular mechanism to inhibit PP2A in this disease [13].